Fatty acid composition of phospholipids and neutral lipids from human diabetic small arteries and veins by a new TLC method

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 59, Issue 6, 1998, Pages 363-369

  Lecomte, M ^a   Claire, M ^a,b   Deneuville, M ^b   Wiernsperger, N ^a  

^a INSERM   (France)

^b Centre Hospitalier Universitaire Pointe a Pitre   (Guadeloupe)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; ELONGATION FACTOR; LIPID; OLEIC ACID; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; TISSUE EXTRACT;

ADULT; AGED; ANIMAL TISSUE; ARTERIOVENOUS SHUNT; ARTERY; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOREARM; FREEZE DRYING; GUADELOUPE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; LIPID COMPOSITION; MALE; NONHUMAN; PRIORITY JOURNAL; SKIN BLOOD FLOW; THIN LAYER CHROMATOGRAPHY; VASCULAR TISSUE; VEIN;

EID: 0032467928     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(98)90097-7     Document Type: Article

References (28)

1. 1. Kannel W. B., McGee D. L. Diabetes and cardiovascular disease: the Framingham study. JAMA 1979; 241: 2035-2038.
2. 2. Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabete Metab 1977; 3: 97-107, 173-182, 245-256.
3. 3. Giugliano D., Ceriello A., Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19: 257-265.
4. 4. Niskanen L. K., Salonen J. T., Nyyssönen K., Uusitupa M. I. J. Plasma lipid peroxidation and hyperglycemia: a connection trough hyperinsulinemia? Diabet Med 1995; 12: 802-808.
5. 5. Baynes J. W. Role of oxidative stress in development of complications of diabetes. Diabetes 1991; 40: 405-412.
6. 6. Wolff S. P., Jiang Z. Y., Hunt J. V. Protein glycation and oxidative stress in diabetes mellitus and aging. Free Radic Biol Med 1991; 10: 339-352.
7. 7. Wolff S. P., Dean R. T. Glucose autoxidation and protein modification: the potential role of autoxidative glycosylation in diabetes. Biochem J 1987; 245: 243-250.
8. 8. Horrobin D. F. Abnormal membrane concentrations of 20 and 22-carbon essential fatty acids: a common link between risk factors and coronary and peripheral vascular disease? Prostaglandins Leukot Essent Fatty Acids 1995; 53: 385-396.
9. 9. Faas F. H., Carter W. J. Altered fatty acid desaturation and microsomal fatty acid composition in the streptozotocin diabetic rat. Lipids 1980; 15: 953-961.
10. 10. Eck M. G., Wynn J. O., Carter W. J., Faas F. H. Fatty acid desaturation in experimental diabetes mellitus. Diabetes 1979; 28: 479-485.
11. 11. Gellhorn A., Benjamin W. The effect of insulin on monounsaturated fatty acid synthesis in diabetic rats. The stability of informational RNA and of the enzyme system concerned with fatty acid desaturation. Biochim Biophys Acta 1966; 116: 460-466.
12. 12. Mercuri O., Peluffo R. O., Brenner R. R. Depression of microsomal desaturation of linoleic to γ-linolenic acid in the alloxan-diabetic rat. Biochim Biophys Acta 1966; 116: 409-411.
13. 13. Borkman M., Storlien L. H., Pan D. A., Jenkins A. B., Chisholm D. J., Campbell L. V. The relation between insulin sensitivity and the fatty acid composition of skeletal muscle phospholipids. N Engl J Med 1993; 328: 238-244.
14. 14. Paolisso G., Howard B. V. Role of non-esterified fatty acids in the pathogenesis of type II diabetes mellitus. Diabet Med 1998; 15: 360-366.
15. 15. Costagliola D., Delaunay C., Moutet J. P. et al. The prevalence of diabetes mellitus on a Carribean Island. Diabetes Res Clin Pract 1991; 12: 209-216.
16. 16. Fontbonne A., Papoz L., Eschwège E., Roger M., Saint-Paul M., Simon D. Features of insulin-resistance syndrome in men from french Caribbean Islands. The Telecom Study. Diabetes 1992; 41: 1385-1389
17. 17. Bligh E. G., Dyer W. J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37: 911-917.
18. 18. Cordonnier D. J., Zmirou D., Benhamou P. Y., Halimi S., Ledoux F., Guiserix J. Epidemiology; development and treatment of end-stage renal failure in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1993; 36: 1109-1112.
19. 19. Das U. N. Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus and coronary heart disease. Prostaglandins Leukot Essent Fatty Acids 1995; 52: 387-391.
20. 20. Singer P., Gnauck G., Honigmann G., Schliack V., Läuter I. The triglyceride fatty acid pattern in arterial wall, adipose tissue and serum of amputated diabetic subjects. Cor Vasa 1978; 20: 202-210.
21. 21. Dang A. Q., Faas F. H., Lee J. A., Carter W. J. Altered fatty acid composition in the plasma, platelets, and aorta of the streptozotocin-induced diabetic rat. Metabolism 1988; 37: 1065-1072.
22. 22. Okumura K., Nishiura T., Awaji Y., Kondo J., Hashimoto H., Ito T. 1, 2-diacylglycerol content and its fatty acid composition in thoracic aorta of diabetic rats. Diabetes 1991; 40: 820-824.
23. 23. El Boustani S., Causse J. E., Descomps B., Monnier L., Mendy F., Crastes de Paulet A. Direct in vivo characterization of delta-5-desaturase activity in humans by deuterium labeling: effect of insulin. Metabolism 1989; 38: 315-321.
24. 24. Morita I., Takahashi R., Ito H., Orimo H., Murota S. Increased arachidonic content in platelet phospholipids from diabetic patients. Prostaglandins Leukot Med 1983; 11: 33-41.
25. 25. Prisco D., Rogasi P. G., Paniccia R. et al. Altered membrane fatty acid composition and increased thromboxane generation in platelets from patients with diabetes. Prostaglandins Leukot Essent Fatty Acids 1989; 35: 15-23.
26. 26. Kalofoutis A., Lekakis J. Changes of platelet phospholipids in diabetes mellitus. Diabetologia 1981; 21: 540-543.
27. 27. Peuchant E., Delmas-Beauvieux M-C., Couchouron A. et al. Short term insulin therapy and normoglycemia: Effects on erythrocyte lipid peroxidation in NIDDM patients. Diabetes Care 1997; 20: 202-207.
28. 28. Labrouche S., Freyburger G., Gin H., Boisseau M. R., Cassagne C. Changes in phospholipid composition of blood cell membranes (erythrocyte, platelet and polymorphonuclear) in different types of diabetes-clinical and biological correlations. Metabolism 1996; 45: 57-62.